Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for treating FLT3 mutation-positive cancer, mutant FLT3 inhibitor and uses thereof

Pharmaceutical composition for treating FLT3 mutation-positive cancer, mutant FLT3 inhibitor and uses thereof

US Patent 9987278 · Granted Jun 5, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for determining presence or absence of suffering from malignant lymphoma 2020
Method for determining presence or absence of suffering from malignant lymphoma 2020
Nitrogen-containing heterocyclic compound or salt thereof2015
Nicotinamide derivative or salt thereof2015
Nicotinamide derivative or salt thereof2014
CD20 negatively converted B-cell malignant lymphoma cell line and utilization th2013
Method for screening candidate compounds for antitumor drug2013
Method for screening candidate compounds for antitumor drug2013
Azo pigments, and pigment dispersion, coloring composition and ink for inkjet re2012
Ink set and inkjet recording method2012
Pyrimidine derivative compound2011
Pyrimidine derivative compound2011